⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
EWTX News
Edgewise Therapeutics, Inc. Common Stock
Form 8-K
sec.gov
EWTX
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
prnewswire.com
EWTX
Servier projette d'acquérir l'activité dystrophie musculaire d'Edgewise Therapeutics USA - Français USA - English USA - English
prnewswire.com
EWTX
Form 8-K
sec.gov
EWTX
Edgewise Therapeutics Announces Sale of Sevasemten for Up to $2.65 Billion, Strengthening Balance Sheet and Centering Company Focus on Cardiovascular Pipeline
prnewswire.com
EWTX
Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business USA - English USA - Français USA - English
prnewswire.com
EWTX
Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business
prnewswire.com
EWTX
Servier projette d'acquérir l'activité dystrophie musculaire d'Edgewise Therapeutics USA - Français USA - English USA - English
prnewswire.com
EWTX
Achieve Life Sciences Strengthens Board and Commercial Leadership with Three Senior Appointments from Team Previously at Verona Pharma
globenewswire.com
ACHV
ORKA
EWTX
Form 8-K
sec.gov
EWTX